![Charles Albright](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Albright
Directeur Technique/Scientifique/R&D chez
Affinia Therapeutics, Inc.
Profil
Charles Albright is currently the Chief Scientific Officer at Affinia Therapeutics, Inc. He previously worked as the VP-Genetically Defined Diseases & Genomics at Bristol Myers Squibb Co. from 2004 to 2016.
He also served as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. from 2016 to 2021.
Albright was an Assistant Professor at Vanderbilt University.
Albright received his undergraduate and doctorate degrees from Massachusetts Institute of Technology.
Postes actifs de Charles Albright
| Sociétés | Poste | Début |
|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Anciens postes connus de Charles Albright
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 15/01/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/08/2016 |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Charles Albright
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
